Caixin
Oct 27, 2021 08:00 AM

Guangdong Vtr Bio-Tech Co.,Ltd.’s Net Profit Dropped 36.1% in First Three Quarters of 2021

Guangdong Vtr Bio-Tech Co.,Ltd. (广东溢多利生物科技股份有限公司) (300381.SZ) reported a net profit of 95.5 million yuan in the first three quarters of 2021, down 36.1% year-on-year.

Meanwhile, the company posted 1.3 billion yuan in revenue, down 10% year-on-year.

At the end of the reporting period, it had 4.6 billion yuan in total assets and 1.4 billion yuan in total liabilities, with a liability-to-asset ratio of 29.8%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.

Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
Caixin Deep Dive: Why Singapore Sovereign Fund Sues Chinese EV-Maker Nio
00:00
00:00/00:00